Last Updated on eMC 25-09-2017 View medicine  | Bayer plc Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to section 6 - manufacturer

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Improved presentation of PIL

Reasons for adding or updating:

  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Updates to formatting

Reasons for adding or updating:

  • Change to date of revision
  • Change to name of manufacturer

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects

Reasons for adding or updating:

  • Change to Further Information section
  • Change to side-effects

Reasons for adding or updating:

  • Change due to harmonisation of PIL.

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Reasons for adding or updating:

  • Change of manufacturer

Reasons for adding or updating:

  • New PIL for new product